Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
BRD0705 is an inhibitor of glycogen synthase kinase 3α (GSK3α; IC50 = 66 nM).1 It is selective for GSK3α over GSK3β (IC50 = 515 nM). BRD0705 (10 and 20 µM) inhibits GSK3α autophosphorylation in U937 cells. It impairs colony formation of MOLM-13, TF-1, U937, MV4-11, HL-60, and NB4 acute myeloid leukemia (AML) cells. In vivo, BRD0705 (30 mg/kg) inhibits leukemia development in secondary recipient mice in an MLL-AF9 mouse syngeneic tumor model.
WARNING This product is not for human or veterinary use.
1. Exploiting an Asp-